Oral rapamycin attenuates atherosclerosis without affecting the arterial responsiveness of resistance vessels in apolipoprotein E-deficient mice

被引:20
作者
Gadioli, A. L. N. [2 ]
Nogueira, B. V. [2 ]
Arruda, R. M. P. [2 ]
Pereira, R. B. [2 ]
Meyrelles, S. S. [2 ]
Arruda, J. A. [2 ]
Vasquez, E. C. [1 ,2 ]
机构
[1] EMESCAM, Escola Super Ciencias, Ctr Pesquisa, BR-29045420 Vitoria, ES, Brazil
[2] Univ Fed Espirito Santo, Ctr Ciencias Saude, Programa Posgrad Ciencias Fisiol, Lab Transgenes & Controle Cardiovasc, Vitoria, ES, Brazil
关键词
Rapamycin; Sirolimus; Atherosclerosis; Vascular responsiveness; Apolipoprotein E; Mice; E KNOCKOUT MICE; SMOOTH-MUSCLE; ELUTING STENTS; SIROLIMUS; CHOLESTEROL;
D O I
10.1590/S0100-879X2009005000036
中图分类号
Q [生物科学];
学科分类号
090105 [作物生产系统与生态工程];
摘要
The objective of the present study was to assess the effects of the immunosuppressant rapamycin (Rapamune (R), Sirolimus) on both resistance vessel responsiveness and atherosclerosis in apolipoprotein E- deficient 8-week-old male mice fed a normal rodent diet. Norepinephrine (NE)-induced vasoconstriction, acetylcholine (ACh)- and sodium nitroprusside (SNP)- induced vasorelaxation of isolated mesenteric bed, and atherosclerotic lesions were evaluated. After 12 weeks of orally administered rapamycin (5 mg.kg(-1).day(-1), N = 9) and compared with untreated (control, N = 9) animals, rapamycin treatment did not modify either NE-induced vasoconstriction (maximal response: 114 +/- 4 vs 124 +/- 10 mmHg, respectively) or ACh- (maximal response: 51 +/- 8 vs 53 +/- 5%, respectively) and SNP-induced vasorelaxation (maximal response: 73 +/- 6 vs 74 +/- 6%, respectively) of the isolated vascular mesenteric bed. Despite increased total cholesterol in treated mice (982 +/- 59 vs 722 +/- 49 mg/dL, P < 0.01), lipid deposition on the aorta wall vessel was significantly less in rapamycin-treated animals (37 +/- 12 vs 68 +/- 8 mu m(2) x 10(3)). These results indicate that orally administered rapamycin is effective in attenuating the progression of atherosclerotic plaque without affecting the responsiveness of resistance vessels, supporting the idea that this immunosuppressant agent might be of potential benefit against atherosclerosis in patients undergoing therapy.
引用
收藏
页码:1191 / 1195
页数:5
相关论文
共 27 条
[1]
Effect of systemic immunosuppression on coronary in-stent intimal hyperplasia in renal transplant patients [J].
Arruda, JA ;
Costa, MA ;
Brito, FS ;
Tedesco, H ;
Barbosa, AHP ;
Ribeiro, ÉP ;
Pestana, JOM ;
Lima, VC .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (11) :1363-1365
[2]
Evaluation of vascular function in apolipoprotein E knockout mice with angiotensin-dependent renovascular hypertension [J].
Arruda, RMP ;
Peotta, VA ;
Meyrelles, SS ;
Vasquez, EC .
HYPERTENSION, 2005, 46 (04) :932-936
[3]
Effect of Sirolimus on the cholesterol content of aortic arch in ApoE knockout mice [J].
Basso, MD ;
Nambi, P ;
Adelman, SJ .
TRANSPLANTATION PROCEEDINGS, 2003, 35 (08) :3136-3138
[4]
Efficacy and safety of oral sirolimus to inhibit in-stent intimal hyperplasia [J].
Brito, FS ;
Rosa, WCM ;
Arruda, JA ;
Tedesco, H ;
Pestana, JOM ;
Lima, VC .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2005, 64 (04) :413-418
[5]
Rapamycin attenuates atherosclerosis induced by dietary cholesterol in apolipoprotein-deficient mice through a p27 Kip1-independent pathway [J].
Castro, C ;
Campistol, JM ;
Sancho, D ;
Sánchez-Madrid, F ;
Casals, E ;
Andrés, V .
ATHEROSCLEROSIS, 2004, 172 (01) :31-38
[6]
Mechanism of action of the immunosuppressant rapamycin [J].
Dumont, FJ ;
Su, QX .
LIFE SCIENCES, 1995, 58 (05) :373-395
[7]
Protective effect of the immunosuppressant sirolimus against aortic atherosclerosis in apo E-deficient mice [J].
Elloso, MM ;
Azrolan, N ;
Sehgal, SN ;
Hsu, PL ;
Phiel, KL ;
Kopec, CA ;
Basso, MD ;
Adelman, SJ .
AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (05) :562-569
[8]
Impaired endothelial vasomotor function after sirolimus-eluting stent implantation [J].
Fuke, Soichiro ;
Maekawa, Kiyoaki ;
Kawamoto, Kenji ;
Saito, Hironori ;
Sato, Tetsuya ;
Hioka, Toru ;
Ohe, Tohru .
CIRCULATION JOURNAL, 2007, 71 (02) :220-225
[9]
Differential effects of drug-eluting stents on local endothelium-dependent coronary vasomotion [J].
Hamilos, Michalis I. ;
Ostojic, Miodrag ;
Beleslin, Branko ;
Sagic, Dragan ;
Mangovski, Ljubco ;
Stojkovic, Sinisa ;
Nedeljkovic, Milan ;
Orlic, Dejan ;
Milosavljevic, Bratislav ;
Topic, Dragan ;
Karanovic, Nevena ;
Wijns, William .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (22) :2123-2129
[10]
Kelly PA, 1997, PHARMACOTHERAPY, V17, P1148